COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 1773: Articles 17721-17730  | Next

Investigation of ventilation conditions associated with CO2 concentration changes in ultrasonographic exam room from the perspective of COVID-19 infection control
Matsubayashi, R. N., Harada, S., Tominaga, M.
10.1101/2021.03.01.21252598 — Posted: 2021-03-02
In vitro evaluation of the activity of terpenes and cannabidiol against Human Coronavirus E229
Chatow, L., Nudel, A., Nesher, I., Hayo Hemo, D., Rozenberg, P., Voropaev, H., Winkler, I., Levy, R., Kerem, Z., Yaniv, Z., Eyal, N.
10.1101/2021.03.01.433501 — Posted: 2021-03-02
Safety and Immunogenicity Evaluation of Inactivated whole-virus-SARS-COV-2 In Mice As Emerging Vaccine Development In Egypt
Ali, A. A., Saad, M. A., Ryan, I., Amin, M., Shindy, M. I., Hassan, W. A., Samir, M., Khattab, A. A., Abdelgayed, S. S., Seadawy, M. G., Fahmy, F. M., Amer, K.
10.1101/2021.03.01.433130 — Posted: 2021-03-02
Fragment-based computational design of antibodies targeting structured epitopes
Aguilar Rangel, M., Bedwell, A., Costanzi, E., Ricagno, S., Frydman, J., Vendruscolo, M., Sormanni, P.
10.1101/2021.03.02.433360 — Posted: 2021-03-02
Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
Wang, P., Wang, M., Yu, J., Cerutti, G., Nair, M. S., Huang, Y., Kwong, P. D., Shapiro, L., Ho, D. D.
10.1101/2021.03.01.433466 — Posted: 2021-03-02
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates
Francica, J. R., Flynn, B. J., Foulds, K. E., Noe, A. T., Werner, A. P., Morre, I. N., Gagne, M., Johnston, T. S., Tucker, C., Davis, R. L., Flach, B., O'Connell, S., Andrew, S. F., Lamb, E., Flebbe, D. R., Nurmukhambetova, S. T., Donaldson, M. M., Todd, J.-P. M., Zhu, A. L., Atyeo, C., Fischinger, S., Gorman, M. J., Shin, S., Edara, V. V., Floyd, K., Lai, L., Tylor, A., McCarthy, E., Lecouturier, V., Ruiz, S., Berry, C., Tibbitts, T., Andersen, H., Cook, A., Dodson, A., Pessaint, L., Ry, A. V., Koutsoukos, M., Gutzeit, C., Teng, I.-T., Zhou, T., Li, D., Haynes, B. F., Kwong, P. D., McDermott, A., Lewis, M. G., Fu, T. M., Chicz, R., van der Most, R., Corbett, K. S., Suthar, M. S., Alter, G., Roederer, M., Sullivan, N. J., Douek, D. C., Graham, B. S., Casimiro, D., Seder, R. A.
10.1101/2021.03.02.433390 — Posted: 2021-03-02
High resolution profiling of MHC-II peptide presentation capacity, by Mammalian Epitope Display, reveals SARS-CoV-2 targets for CD4 T cells and mechanisms of immune-escape
Obermair, F. J., Renoux, F., Heer, S., Lee, C., Cereghetti, N., Maestri, G., Haldner, Y., Wuigk, R., Iosefson, O., Patel, P., Triebel, K., Kopf, M., Swain, J., Kisielow, J.
10.1101/2021.03.02.433522 — Posted: 2021-03-02
High-content screening of coronavirus genes for innate immune suppression revealsenhanced potency of SARS-CoV-2 proteins
Olson, E. J., Brown, D. M., Chang, T. Z., Ding, L., Ng, T. L., Weiss, H. S., Koch, P., Koide, Y., Rollins, N., Mach, P., Meisinger, T., Bricken, T., Rollins, J., Zhang, Y., Molloy, C., Zhang, Y., Queenan, B. N., Mitchison, T., Marks, D., Way, J. C., Glass, J. I., Silver, P. A.
10.1101/2021.03.02.433434 — Posted: 2021-03-02
Impact of COVID-19 on healthcare workers at a cancer care centre
Dogra, A., PARKASH, A., Mehta, A., Bhatia, M.
10.1101/2021.02.28.21252181 — Posted: 2021-03-02
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity
Truong, T. T., Ryutov, A., Pandey, U., Yee, R., Goldberg, L., Bhojwani, D., Aguayo-Hiraldo, P., Pinsky, B. A., Pekosz, A., Shen, L., Boyd, S. D., Wirz, O. F., Roltgen, K., Bootwalla, M., Maglinte, D. T., Ostrow, D., Ruble, D., Han, J. H., Biegel, J. A., Li, M., Huang, C., Sahoo, M. K., Pannaraj, P. S., O'Gorman, M., Judkins, A. R., Gai, X., Dien Bard, J.
10.1101/2021.02.27.21252099 — Posted: 2021-03-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).